(HealthDay)—For premenopausal women with breast cancer, two years of tamoxifen is associated with long-term survival benefit, according to a study published online May 9 in the Journal of Clinical Oncology.
May 12, 2016
0
5
There's no doubt estrogen plays a big role in the differences between males and females, and now researchers want to know if it also helps explain emerging sex differences in what makes younger, obese men and women hypertensive.
Feb 16, 2016
0
10
(HealthDay)—Vitamin D deficiency is associated with dry eye and impaired tear function, according to a study published in the January issue of the International Journal of Rheumatic Diseases.
Feb 10, 2016
0
2
The incidence and severity of both traditional and emerging cardiovascular disease (CVD) risk factors as well as the response to treatment may differ between genders. In this narrative review, several emerging CVD risk factors ...
Feb 4, 2016
0
0
Premenopausal women whose invasive breast cancers were of the luminal A subtype had comparable 10-year disease-free survival rates regardless of whether or not they received adjuvant chemotherapy, according to data from the ...
Dec 9, 2015
0
1
(HealthDay)—Uptake of the women's libido-boosting pill flibanserin (Addyi) has been slow since its approval, according to a report published by Bloomberg Business.
Nov 21, 2015
0
3
Premenopausal women diagnosed with breast cancer following a biennial screening mammogram were more likely to have bigger more advanced tumors than women screened annually, while postmenopausal women not using hormone therapy ...
Oct 20, 2015
0
8
Everyone knows that exercise is good for you, regardless of your age. But a new study coming out of the University of Massachusetts Amherst and presented earlier this month at the 2015 annual meeting of The North American ...
Oct 19, 2015
0
329
(HealthDay)—Metabolic syndrome is common in young, premenopausal women with systemic lupus erythematosus (SLE), and chloroquine appears to protect against metabolic syndrome in these women, according to a study published ...
Sep 17, 2015
0
8
Concerns about fertility kept a third of young women with breast cancer from taking tamoxifen, despite its known benefit in reducing the risk of breast cancer coming back.
Aug 24, 2015
0
59
